A biopharmaceutical company with British-Swedish roots, AstraZeneca Pharma Poland, plans to open a second office in Poland in Kraków in July this year, the company said. As part of the new investment, AstraZeneca plans to develop close cooperation with Sano – Center for Individualized Computational Medicine dealing with the development of computer medicine.
Employees of the new office in Kraków, which will be located in the vicinity of the AGH University of Science and Technology Stanisława Staszica, will focus on the latest computer systems used during a clinical trial in the area of research process management or collection of clinical data, as well as managing the course of global clinical trials.
"Kraków is an excellent location for such investments – it is one of the leading academic centers in the country, the business center of southern Poland and the seat of many medical and biotechnology startups, as well as those operating in the field of IT, AI and data management," Barbara Kozierkiewicz, VP of AstraZeneca Pharma Poland, said.
As part of the new investment, AstraZeneca envisages the development of close cooperation with Sano – Center for Individualized Computational Medicine, an international research foundation, i.e. an institute dealing with the development of computer medicine.
In Poland, AstraZeneca employs approximately 2,300 people, of which over 1,500 are involved in key research and development processes worldwide. In 2020, AstraZeneca was the first global biotechnology company to obtain the status of a Research and Development Center awarded by the Minister of Development.